Wells Fargo’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
VCM
SWM
Wells Fargo's SMTI Position: Q1 2026 in Review
Wells Fargo reduced its Sanara MedTech (SMTI) stake by 67% in Q1 2026, selling an estimated $45.7K and leaving 1,102 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5794.
Wells Fargo first reported a position in SMTI in Q4 2020 and has held it in 22 quarters since. The position peaked at $77.6K in Q4 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.
- Wells Fargo held 1,102 shares of Sanara MedTech worth $18.9K as of Q1 2026.
- Wells Fargo sold 2,220 Sanara MedTech shares in Q1 2026, an estimated $45.7K.
- Sanara MedTech made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5794 holding.
- Wells Fargo first reported a position in Sanara MedTech in Q4 2020 and has held it in 22 quarters since.
- Wells Fargo's Sanara MedTech position peaked at $77.6K in Q4 2025.
- 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.